Lilly’s stock rallies as sales of GLP-1 drugs nearly double
MarketWatch1 min readPaywall
Read Full Article at MarketWatch →Ad Slot — In-Article (728x90)
Sales of Mounjaro and Zepbound both beat expectations
This is a summary. For the full story, read the original article at MarketWatch.
Original source: MarketWatch